Loading...
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
INTRODUCTION: Currently available endothelin receptor antagonists for treating pulmonary arterial hypertension block either the endothelin (ET) receptor A or both A and B receptors. Transition from one endothelin receptor antagonist to another may theoretically alter side-effects or efficacy. We rep...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3064451/ https://ncbi.nlm.nih.gov/pubmed/21468170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S15026 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|